These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3350395)

  • 1. Reduced fibrinolytic potential in patients with arterial occlusive disease (AOD) in comparison with normal subjects.
    Hartl D; Tiso E; Anderle K; Philapitsch A; Anger G
    Haemostasis; 1988; 18 Suppl 1():93-8. PubMed ID: 3350395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis.
    Badylak SF; Voytik SL; Henkin J; Burke S; Sasahara AA; Simmons A
    Haemostasis; 1991; 21(5):278-85. PubMed ID: 1806456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of urokinase-induced thrombolysis in a biphasic in vitro system.
    Iga Y; Stella SR; Chandler AB
    Haemostasis; 1985; 15(3):189-97. PubMed ID: 4029755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of local fibrinolysis in abortion.
    Ikeuchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intraarterial plasminogen application in combination with percutaneous transluminal angioplasty (PTA) or catheter assisted lysis (CL) in patients with chronic peripheral occlusive disease of the lower limbs (POL).
    Tilsner V; Witte G
    Haemostasis; 1988; 18 Suppl 1():139-56. PubMed ID: 2965085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiated thrombolysis in a Chandler system using rtPA and lys-plasminogen.
    Ljungberg J; Hedner U
    Thromb Res; 1989 Mar; 53(6):569-76. PubMed ID: 2499945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
    Lijnen HR; De Wreede K; Demarsin E; Collen D
    Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion.
    Ebben HP; Nederhoed JH; Slikkerveer J; Kamp O; Tangelder GW; Musters RJ; Wisselink W; Yeung KK
    J Vasc Surg; 2015 Aug; 62(2):477-85. PubMed ID: 24768365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
    Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
    Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute peripheral arterial and graft occlusion: treatment with selective infusion of urokinase and lysyl plasminogen.
    Pernes JM; Vitoux JF; Brenoit P; Raynaud A; Parola JL; Roth JP; Angel CY; Fiessinger JN; Roncato M; Gaux JC
    Radiology; 1986 Feb; 158(2):481-5. PubMed ID: 3941877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.